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A plasmid containing a single cloned insertion of Haemophilus influenzae
chromosomal deoxyribonucleic acid that carried a novobiocin resistance marker
was 2.6 times larger than the parent plasmid, RSF0885, which conferred ampicillin
resistance. The most frequent type of transformation by this plasmid (designated
pNovl) was the transfer of novobiocin resistance to the chromosome, with the
loss of the plasmid from the recipient. In accord with this observation, after
radioactively labeled pNovl entered a competent cell, it lost acid-insoluble counts,
as well as biological activity. The level of ampicillin transformation, which
involved establishment of the plasmid, was almost two orders of magnitude lower
than the level of novobiocin transformation. Both types of transformation were
depressed profoundly in rec-1 and rec-2 mutants. Ampicillin transformants of
wild-type cells always contained plasmids that were the same size as pNovl,
although most of these transformants were not novobiocin resistant. Plasmid
pNovl in wild-type cells but not in rec-1 or rec-2 cells often recombined with the
chromosome, causing a homologous region of the chromosome to be substituted
for part of the plasmid, as shown by restriction and genetic analyses. Our data
suggested that plasmid-chromosome recombination took place only around the
time when the plasmid entered a cell, rather than after it became established.
Originally, cloning ofHaemophilus influenzae
DNA with an H. influenzae plasmid vector was
undertaken in our laboratory in an attempt to
analyze the products of various chromosomal
loci where we isolated mutants defective in a
number of aspects of genetic recombination and
DNA repair. We have been sidetracked from
this goal completely because ofsome unexpected
phenomena which we observed in transforma-
tion by plasmids containing cloned fragments.
The most important of these are (i) that one
type of transformation involves integration of
some of the cloned chromosomal DNA into the
recipient chromosome, with a loss ofthe plasmid
and the original plasmid antibiotic resistance
marker, and (ii) that another type of transfor-
mation, in which a plasmid becomes established
in the recipient cell and is the same size as the
transforming plasmid, usually has the cloned
DNA part of the plasmid altered. Thus, in most
ofthe transformations where there is an addition
of a plasmid to a recipient cell, the genetic
marker of the cloned fragment in the incoming
plasmid is lost and apparently is replaced by a
segment of chromosomal DNA. In this study we
investigated these phenomena.
MATERIALS AND METHODS
Microorganisms, transformation, gel electrophore-
sis, plasmid preparation, and electron microscopy
methods are described in the accompanying paper (9).
Construction ofplasmids containing cloned in-
sertions. Purified RSF0855 and H. influenzae DNA
containing eight antibiotic resistance markers were
digested to completion with the restriction endonucle-
ase PvuII, as described in the accompanying paper (9).
Ligation was performed for 2 h at 14°C in a reaction
mixture (0.02 ml) containing 1 U of T4 ligase (New
England Biolabs), 5 jig of plasmid DNA per ml, 1 jAg of
chromosomal DNA per ml, 66mM Tris-hydrochloride
(pH 7.5), 6.6 mM MgCl2, 66 MM ATP, 10 mM dithio-
threitol, and 20 mM spermidine (Sigma Chemical Co.).
Construction of library and isolation of cells
containing particular genes. Competent strain
BC200 cells were exposed to 0.03 Mg of ligated DNA
per ml, resulting in 9.5 x 103 transformants to ampi-
cdllin per ml. (Transformants were measured by plat-
ing the cells after exposure, incubating them for 90
min at 37°C, and then layering the plates with agar
containing 10,ug of ampicillin per ml.) Selection was
made by overnight growth in a liquid culture contain-
ing 1 MLg of ampicillin per ml after expression in liquid
growth medium, as described previously (11). Each
ampicillin-resistant culture was stored frozen in 14%
glycerol for future study. Samples were plated with
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various antibiotics to isolate cells that were resistant
to ampicillin and also contained a chromosomal
marker. One of the larger plasmids, designated pNovl,
was selected by plating with 2.5,ug of novobiocin per
ml.
Measuring plasmid lengths. Electron microscope
images on negatives were magnified 10-fold on the
screen of a Nikon profile projector. Tracings were
made, and the plasmid lengths were determined with
a Numonics electronic digitizer.
Restriction endonuclease analysis. PvuII diges-
tion was as described in the accompanying paper (9).
TaqI (New England Biolabs) digestion was carried out
at 65°C for 1 h in a 0.05-ml reaction mixture containing
10 mM Tris-hydrochloride (pH 8), 6 mM MgCl2, 100
mM NaCl, 6 mM beta-mercaptoethanol, 4 to 6 ,ug of
plasmid DNA, and 7 U of enzyme.
Curing. Curing plasmid-bearing strains of their
plasmids was done in liquid cultures containing 17 jug
of acridine orange per ml, except for the Rec- strains,
where only one-half this concentration was used. Cells
were grown for approximately six generations with
acridine orange and then plated onto the surfaces of
agar plates. The next day colonies were transferred
with toothpicks to plates containing ampicillin or no
drug. Each colony was also tested for novobiocin re-
sistance.
Radioactively labeled plasmid. Cells were grown
with aeration in 8 ml of brain heart infusion medium
containing 10,g of hemin per ml and 3 ,ug of NAD per
ml to a density of approximately 10' cells per ml. Then
33 MCi of [3H]thymidine (52 Ci/mmol) per ml was
added, and growth was continued to saturation (under
these conditions the specific activity of both plasmid
DNA and chromosomal DNA was approximately 105
cpm/,ug). A crude plasmid preparation was then made
(9). This preparation was centrifuged at 32,000 rpm
for 2 h in a 5 to 20% sucrose gradient containing 0.15
M NaCl and 0.015 M trisodium citrate in a Beckman
SW50.1 rotor, assayed for radioactivity and transform-
ing activity, and, in some cases, run on a gel. Under
these conditions the residual chromosomal DNA in
the plasmid preparation sedimented separately and
faster than the plasmid DNA (data not shown). To
investigate the fate of plasmid DNA during transfor-
mation, 12 ml of competent cells was exposed to 0.2
ml of the peak plasmid fraction from the sucrose
gradient for 10 min at 37°C; then 20 Mg of DNase per
ml was added, and after a further incubation for 3 min
at 37°C the mixture was centrifuged and resuspended
at the same concentration in fresh MIV (12). Samples
(4 ml) were withdrawn 0, 30, and 60 min later, and a
crude plasmid preparation was made from each sample
(9). The samples were then centrifuged for 2.25 h at
33,000 rpm. Approximately 12 fractions were collected
from each sample in test tubes; a portion of each
fraction was spotted onto paper and processed as
previously described (3), and a portion was assayed for
transforming activity.
RESULTS
Electron microscope determinations. Ta-
ble 1 shows the electron microscopic measure-
ments for plasmids pNovl and RSF0885, com-
pared with a plasmid pBR322 standard, since
the size of the latter is known very precisely
from a base sequence determination (13). The
molecular weight of plasmid RSF0885 from
these data was 3.7 x 106. Previous determina-
tions of the molecular weight of this plasmid
were 3.6 x 106 from gel data and 3.2 x 106 from
electron microscopy without a standard (7). An-
other value from sedimentation velocity, gel
electrophoresis, and electron microscopy was 4.1
x 106 (10). The molecular weight of pNovl was
9.6 x 106 (Table 1).
Restriction analyses of the plasmids. The
results of PvuII digestions of pNovl and
RSF0885 are shown in Fig. 1. This restriction
endonuclease made a single cut in RSF0885,
resulting in a single band. In both cases before
digestion there were two bands, which were from
the relaxed forms and the supercoiled forms of
the plasmids. After being cut by PvuII, the larger
plasmid (plasmid pNovl) showed two bands,
one of which appeared to be identical to the
single band of enzyme-treated RSF0885. The
second band of pNovl migrated more slowly
than the first, indicating that this DNA was
larger. These data showed that pNovl contained
only a single insertion of chromosomal DNA.
The relative size of the chromosomal portion
was consistent with the data in Table 1, in that
the insertion in pNovl was larger than the
RSF0885 portion.
Figure 2 shows the results of digestions of
pNovl and RSF0885 with TaqI. The digested
original plasmid (plasmid RSF0885) showed
seven bands. With pNovl six of these bands
were present, and there were five additional
bands.
DNA concentration dependence of trans-
formation by pNovl. Figure 3 shows the dose-
response curves for purified pNovl. The level of
transfornation to novobiocin resistance from
pNovl was almost two orders of magnitude
higher than the level of transfornation to am-
picillin resistance from this plasmid. The level
of novobiocin transformation was more than
TABLE 1. Electron microscope measurements of
RSF0885 andpNovl, usingpBR322 as a standard
No. of Ratio of
mole- Magni- Measured No. of length to
Plasmid cules fication baseRS85
mea- (xI03) lengh(cm) pa RSF085
sured length
pBR322 11 219 26.8 ± 1.60 4,362 0.77
RSF0885 18 219 35.0 + 1.0 5,700 1.0
pBR322 19 270 33.3 ± 1.1
pNovl 10 270 115.7 ± 3.1 15,100 2.6
a Mean + standard deviation.
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a b cd Effect of PvuH digestion on transforma-tion by pNovl. PvuII treatment resulted in a
complete loss of the ability to transform to am-
picillin resistance; undigested pNovl from the
sample shown in Fig. 1 produced 1.0 x 105 am-
picillin transformants per ml, whereas digested
pNovl produced <102 ampicillin transformants
per ml. However, transformation to novobiocin
resistance was increased by PvuII treatment.
Undigested pNovl produced 4.8 x 106 novobio-
cin transformants per ml, whereas digested
pNovl produced 3.1 x 107 novobiocin transform-
ants per ml; this suggested that the nonhomol-
ogous part of plasmid pNovl (from the parent,
RSF0885) interfered with transformation when
it was attached to chromosomal DNA.
Nature ofthe transformants from pNovl.
To obtain information on the nature ofthe trans-
formation that took place when competent cells
were exposed to plasmid DNA containing an
insertion, we isolated three different kinds of
transformants: ampicillin transformants, trans-
four orders of magnitude higher than the level
of transformation for any marker from residual
chromosomal DNA in preparations that were
centrifuged twice through cesium chloride-
ethidium bromide (data not shown).
Rec gene dependence of transformation
by pNovl. Transformation by RSF0885 is not
affected by the rec-1 and rec-2 mutations (9),
but this was not the case for pNovl. The ampi-
cillin transformation efficiency was considerably
lower for the Rec- strains than for the wild type.
A crude preparation of pNovl produced 2.5 x
104 ampicillin transformants per ml with wild-
type strain Rd, whereas it produced 25 and 60
ampicillin transformants per ml with rec-I and
rec-2 mutants, respectively. Transformation of
the Rec- strains to novobiocin resistance by the
plasmid was not observed under the conditions
used. Transformation by chromosomal DNA is
also very low in these strains (11).
FIG. 2. Gel electrophoresis ofplasmids after diges-
tion with restriction endonuclease TaqI. Lane a,
RSF0885; lane b, pNovl.
FIG. 1. Gel electrophoresis of two plasmids before
and after digestion with restriction endonuclease
PvuII. Lane a, RSF0885; lane b, digested RSF0885;
lane c, pNovl; lane d, digested pNovl.
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formants expressing only the inserted chromo-
somal marker, and double transformants from
both of these. The following determinations
were made for these transfornants: whether
they contained plasmids, the sizes of the plas-
mids, whether the cells were resistant to the
unselected marker (either ampicillin or novobio-
cin), and whether crude plasmid preparations
from the transformants (containing some chro-
mosomal DNA, as well as plasmid DNA) trans-
formed for these markers. However, even in
these crude (cleared lysate) plasmid prepara-
tions the residual chromosomal DNA trans-
formed with a frequency several orders of mag-
nitude lower than the novobiocin marker from
the plasmid (data not shown).
Table 2 shows the results of some of these
determinations. Ampicillin resistance was al-
ways accompanied by the presence of a plasmid.
The same was true of 60 other transformants of
other types (data not shown). Thus, the ampi-
cillin marker rarely or never entered the chro-
mosome, or else it was not expressed if it was in
the chromosome. The latter hypothesis is in-
probable, since another ampicillin marker in H.
influenzae is expressed either on a plasmid or
(a)
Novobgocin
06
7 K0 Ampicillin
0
z
10Ins
0.05 o0. 1.0 10.0
,ug/ml PLASMID DNA
FIG. 3. Transformation by pNovl as a function of
DNA concentration.
TABLE 2. Characteristics of wild-type cells
transformed bypNovl
No. of Presence Approx Expres- Resist-
Selection trans- of plas- size of sion of ance toSlcon formants ofd plasmof cloned ampi-
studied mid s plasmids marker cillin
Ampicillin 20 20/20a All like 5/20a 20/20a
pNovl
Novobiocin 17 0/17 17/17 0/17
Ampicillin + 13 13/13 All like 13/13 13/13
novobiocin pNovl
Number positive/number tested.
when integrated into the chromosome (1, 2).
When the selection was for the chromosomal
marker, in no case was there also ampicillin
resistance or a plasmid in the transformant.
Thus, double transformants from these plasmids
were rare. The transformants for the chromo-
somal marker contained DNA that had become
integrated into the chromosome in the usual
place, as judged by the normal streptomycin-
novobiocin marker linkage shown by lysates of
10 novobiocin transformants of streptomycin-re-
sistant cells (data not shown). Thus, it is im-
probable that a significant amount of plasmid
DNA became integrated along with the chro-
mosomal marker from the plasmid.
The most remarkable result in Table 2 is that
after ampicillin selection in wild-type cells, there
were relatively few cases of expression of the
cloned marker from the plasmid used for the
transformation, although the plasmids in the
transformants were the same size as the plasmid
used to produce the transformant. Cell-free
preparations of all of the transformants were
tested for the ability to transform for the unse-
lected chromosomal marker. Such a transfor-
mation occurred only in cases where novobiocin
resistance was expressed in the transformant
(thus, in only 5 of 20 ampicillin transformants
from pNovl).
It is clear that even though almost all of the
ampicillin transformants lost the chromosomal
marker from the plasmid used for the transfor-
mation, they still contained chromosomal DNA
in their plasmids, as judged by the size of the
plasmids inside them and the fact that there was
high ampicillin transformation from plasmid
preparations of these transformants (data not
shown), partly because of specific DNA uptake
sites not present in the parent plasmid (9). Thus,
the original chromosome material was replaced
or altered.
In contrast to the data of Table 2, 10 ampicillin
transformants of rec-1 and 17 ampicillin trans-
formants of rec-2 were novobiocin resistant.
Natwue of the changed chromosomal
DNA in pNovl transformants. The experi-
ments described below were performed to obtain
information on the chromosomal insertions in
plasmids from wild-type transformants. Plas-
mids were purified from the following three
types of transformants selected for ampicillin
resistance: (i) novobiocin-sensitive transform-
ants, (ii) novobiocin-resistant transformants in
which novobiocin resistance was not specified
by the chromosome of the recipient (as deter-
mined by curing the strain of the plasmid), and
(iii) novobiocin-resistant transformants in which
both the chromosome and the plasmid carried
the resistance marker (as deternined by curing
VOL. 148, 1981
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FIG. 4. Gel electrophoresis of TaqI digests ofplas-
mids from novobiocin-sensitive transformants (lane
a), plasmids from novobiocin-resistant transformants
ofpNovl (lanes b and c), and pNovl (lane d). The
transfonnant from which the preparation in lane b
was isolated was novobiocin sensitive after curing,
and the transformant from which the preparation in
lane c was isolated was resistant after curing.
and high novobiocin transformation by a puri-
fied plasmid preparation). As Fig. 4 shows, all of
these transformants produced the same TaqI
restriction digestion pattern, and this pattern
was identical to the pattern of the original plas-
mid, pNovl. This suggested that the chromo-
somal material in the plasmids of the novobio-
cin-sensitive transformants could have been re-
placed by the corresponding part of the DNA of
the novobiocin-sensitive recipient. To test this
hypothesis, competent wild-type cells which
were novobiocin resistant were exposed to puri-
fied plasmid DNA from a novobiocin-sensitive
transformant; these cells were allowed to grow
for a number of generations and then were
plated nonselectively. Colonies were picked and
transferred with toothpicks to plates with and
without novobiocin. Of 151 colonies from cells
not exposed to DNA, none was novobiocin sen-
sitive, whereas 218 of the 260 colonies from cells
exposed to DNA were novobiocin sensitive. The
transformation to novobiocin sensitivity was ex-
traordinarily high, even considering that there
were approximately 25 plasmids per cell at the
time of exposure. It was clear that the plasmid
DNA carried the genetic information for novo-
biocin sensitivity, which it must have acquired
from a recipient novobiocin-sensitive cell.
The results described above implied that if a
recipient cell contained the novobiocin resist-
ance marker, an ampicillin transformant trans-
formed by pNovl should contain only plasmids
with the novobiocin resistance marker. A total
of 12 ampicillin transformants from a novobio-
cin-resistant strain that was also resistant to
other antibiotics were selected after exposure to
pNovl. The plasmids of nine of these transform-
ants were purified and tested for the ability to
transform sensitive cells to novobiocin resist-
ance. In all cases, the frequency of transforma-
tion to novobiocin resistance was more than
three orders of magnitude higher than the fre-
quency of transformation to any other antibiotic
resistance conferred by the residual chromo-
somal DNA of the recipient (data not shown).
The DNAs of the other three ampicillin trans-
formants were tested by assaying the DNA of a
crude plasmid preparation for transformation to
novobiocin resistance before and after the DNA
was placed in boiling water for 4 min. This
procedure decreased the transformation by
chromosomal DNA but increased the transfor-
mation by plasmid DNA because of decreased
competition (9). We found that the novobiocin
resistance marker was present in the plasmids of
all three of these transformants (data not
shown). The fact that the novobiocin resistance
marker was present in the plasmids of 12 of 12
ampicillin transformants from novobiocin-resist-
ant cells, in contrast to the lack of novobiocin
resistance in 75% of the pNovl transformants
from novobiocin-sensitive cells (Table 2), is ad-
ditional evidence that the plasmid could lose a
marker by acquiring homologous genetic infor-
mation from a sensitive recipient cell.
Evidence that the recombination be-
tween plasmid and chromosome that re-
sults in transfer of a plasmid marker to the
chromosome takes place only during the
original transformation. It might be imagined
that a resident plasmid could recombine with
the chromosome at any time during growth of
the cells. However, this seems not to be the case.
Novobiocin-resistant transformants of strains
BC200 and Rd that were exposed to pNovl and
selected for ampicillin resistance were grown
from single colonies for about five generations
J. BACTrERIOL.
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and then exposed to acridine orange. The sur-
vivors of this treatment that were ampicillin
sensitive (and thus without plasmids) were
tested for sensitivity and resistance to novobio-
cin. Table 3 shows that in two cases the cells
freed of the plasmid had previously acquired the
novobiocin resistance marker, but the other 13
isolates were still novobiocin sensitive, as they
were before the plasmid transformation. After
curing the progeny of each original transformant
all were of one type (either novobiocin sensitive
or novobiocin resistant); one set of progeny
never contained both types. These data sug-
gested that the acquisition of the novobiocin
resistance marker by the cell chromosome oc-
curred before the first division after transfor-
mation by pNovl and not at some later time
during growth.
A total of 10 novobiocin-resistant rec-1 and 17
rec-2 ampicillin transfornants were also cured,
and we found no evidence of transfer of novobio-
cin resistance to the cell chromosome, since the
cured cells were all novobiocin sensitive.
The state of competence itself is apparently
not a sufficient condition for transfer ofa marker
from plasmid to chromosome, since we obtained
evidence that an established pNovl plasmid did
not recombine with the chromosome when the
cells were made competent. In this expeximent
wild-type cells containing pNovl but lacking the
novobiocin marker in the chromosome were
grown, made competent, and then regrown in
acridine orange for curing. Of 310 cured progeny,
none was novobiocin resistant. These data sug-
gested that the established plasmid was seques-
tered from the chromosome.
Experiments with radioactively labeled
TABLE 3. Novobiocin resistance and sensitivity in
cured progeny ofpNovl transformants of strains Rd
and BC200
Ampicillin trans£ornantsa No. of cured Resistance
Strain Isolate progeny tested to novobio
Rd 1 208 All-
2 11 All-
3 6 All-
4 51 All-
5 50 All-
6 52 All-
7 52 All-
8 52 All-
9 52 All-
10 50 All+
BC200 1 8 AU1-
2 11 All-
3 3 All +
4 10 All-
5 7 All-
a Also novobiocin resistant.
plasmids. Plasmid DNA from one of the am-
picillin-novobiocin transformants of plasmid
pNovl (Table 2) was isolated from a culture
grown with [3H]thymidine, and the profiles of
radioactivity and biological activity were deter-
mined after sedimentation through sucrose gra-
dients (Fig. 5). It is interesting that transforma-
tion for novobiocin and the radioactivity pattern
almost coincided, but the ampicillin and ampi-
cillin-novobiocin transformation patterns ap-
peared to be shifted slightly to the faster-sedi-
menting side of the gradient. This could mean
that the open circular forn of the plasmid was
better for transformation by the inserted chro-
mosomal marker, whereas the closed circular
form was better for ampicillin transfornation, as
shown in the accompanying paper for RSF0885
transformation (9). An alternative hypothesis is
that establishment of the plasmid may be fa-
vored when there is a rare dimer form.
We can rule out the possibility that chromo-
somal contamination played a role here, since
chromosomal DNA sedimented to the bottom of
the tube under the conditions of the experiment.
In addition, the amounts of residual chromo-
somal DNA in cleared lysates were much too
low to have any effect on the high frequency of
novobiocin transformation (10%).
A peak fraction from a preparation like that
Z i
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2 x 10l
xiO5
[35 x O1
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Z 12XI5
10 9 xio
6,c10
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z 4.0XI0o
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3 x 0
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X103
ah S*3, 3 7 Ot
3 5 7 9 I11
FRACTION NUMBER
FIG. 5. Sucrose gradient profiles of radioactively
labeledplasmid DNA. Sedimentation was from right
to left.
VOL. 148, 1981
E
810 SETLOW ET AL.
used for Fig. 5 was used to transform competent
cells. To follow the fate of plasmids that entered
the cells, samples were withdrawn at different
times after DNA uptake Iwas terminated by
DNase treatment, and a similar plasmid prepa-
ration was made and fractionated on a sucrose
gradient (Fig. 6). Again, the peak position-of the
radioactive counts was close to the peak of no-
vobiocin transformation, whereas the ampicil-
lin and ampicillin-novobiocin transfornations
formed a peak one fraction nearer the bottom.
Also, the radioactivity counts showed that there
was a considerable progressive loss of acid-insol-
uble radioactivity, and there was a small fraction
of the material near the bottom of the gradient
that exhibited lower biological activity. There
was also much loss of biological activity from 0
to 60 min, particularly for ampicillin transfor-
mation, but little or no evidence of biologically
active DNA near the bottom of the gradient.
Nevertheless, at least at early times, much of
the input plasmid DNA was recovered in a bio-
logically active form when it was reextracted.
DISCUSSION
RSF0885 contains a defective TnA sequence
(4), and thus it is not surprising that the ampi-
cillin marker does not enter the host chromo-
some by transposition. The fact that RSF0885
transformation to ampicillin resistance is inde-
pendent of Rec genes (9) is also easy to explain,
since it can be assumed that the plasmid enters
the cell and can become established without
interacting with the recipient chromosome; thus,
recombination is not involved. However, the fact
that ampicillin transformation from plasmids
FRACTION NUMBER
FIG. 6. Sucrose gradient profiles of radioactively
labeled plasmid DNA at different times after en-
trance into competent cells. Sedimentation was from
right to left.
containing chromosomal insertions is depressed
profoundly in Rec- strains (see above) does not
have an obvious explanation. One possibility is
that the presence of a chromosomal insertion
stabilizes the plasmid by pairing at a homolo-
gous site on the chromosome. The rec-2 mutant
lacks the ability to permit pairing between trans-
forming DNA and recipient DNA (8), because
competent cell DNA in this strain does not form
the gaps and tails suitable for pairing (5, 6). The
rec-1 mutant does form such structures, but is
prevented from forming recombinants appar-
ently because of local breakdowns at pairing
sites (5). Thus, it might be expected that the
pNovl plasmids inside rec-1 and rec-2 mutants
are more unstable than the pNovl plasmids in
wild-type cells.
We have presented evidence for two types of
rec-l- and rec-2-dependent recombination be-
tween a plasmid containing a chromosomal in-
sertion and the chromosome. Both types appar-
ently occur only at a time shortly after a plasmid
enters a competent cell. Thus, there is very rare
or no recombination between an established
plasmid and the chromosome, even when the
celLs are made competent. In one type of recom-
bination the insertion replaces the homologous
region in the chromosome, and the plasmid is
usually but not always lost. Our data on the
intracellular fate of plasmid radioactivity and
markers (Fig. 6) reflect the disintegration of the
plasmid and the loss of the ampicillin marker in
particular. In the other type of plasmid-chro-
mosome recombination, the plasmid acquires a
homologous region of the chromosome in place
of part or all of the insertion. We do not believe
that these two types usually occur in the same
recombination event, since we have not found
ampicillin transformants of pNovl in which the
chromosome carries the novobiocin resistance
marker and the plasmid carries the correspond-
ing sensitivity marker, as would be expected
from reciprocal recombinatiop. Furthermore,
the frequency of transformation by the inserted
marker of pNovl is much higher than that of
ampicillin (Fig. 3). The ampicillin transformants
are more likely to have lost novobiocin resist-
ance altogether than to have this marker in the
chromosome of the cell (Tables 2 and 3). When
both the plasmid and the cell carry the novobio-
cin resistance marker, it is likely that one plas-
mid has recombined with the chromosome and
disintegrates after donation of the resistance
marker and another plasmid has become estab-
lished in the cell.
We have considered the possibility that the
original transformant of the ligated DNA of
pNovl could contain a mixture of plasmids
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carrying novobiocin resistance and sensitivity
markers. If this is the case, then the fraction of
plasmids carrying sensitivity markers must be
relatively low, since no novobiocin-sensitive am-
picillin transformants were obtained when recip-
ients already carrying the novobiocin resistance
marker were exposed to pNovl and no novobio-
cin-sensitive ampicillin transformants of rec-1
and rec-2 were found.
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